| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |